Mortality and renal disease in type 1 diabetes mellitus - Progress made, more to be done

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 10, 2006, Pages 3757-3759

  Maahs, David M ^a   Rewers, Marian ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

BLOOD PRESSURE; CARDIOVASCULAR RISK; DISEASE CONTROL; EDITORIAL; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MORTALITY; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK FACTOR; UNITED STATES; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; HUMAN; KIDNEY TRANSPLANTATION; NOTE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY TRANSPLANTATION; RENAL DIALYSIS;

EID: 33749545733     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1730     Document Type: Editorial

References (31)

1. Stadler M, Auinger M, Anderwald C, Kästenbauer T, Kramar R, Feinböck C, Irsigler K, Kronenberg F, Prager R 2006 Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus. J Clin Endocrinal Metab 91:3814-3820
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T 1983 Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501
3. Deckert T, Poulsen JE, Larsen M 1978 Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis. Diabetologia 14:371-377
4. Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, Becker DJ, Cavender DE, Drash AL 1984 The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33:271-276
5. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH; American Diabetes Association 2003 Diabetic nephropathy. Diabetes Care 26(Suppl 1):S94-S98
6. Gordois A, Scuffham P, Shearer A, Oglesby A 2004 The health care costs of diabetic nephropathy in the United States and the United Kingdom. J Diabetes Complications 18:18-26
7. Dabelea D, Maahs DM, Snively BM, Bell RA, Dolan LM, Hirsch IB, Imperatore GA, Liese AD, Mayer-Davis EJ, Pettitt DJ, Rodriguez BL, for the SEARCH for Diabetes in Youth Study Group 2005 High prevalence of elevated albumin excretion in youth with type 2 diabetes: the SEARCH for Diabetes in Youth Study. Diabetologia 48(Suppl 1):A53-A54
8. Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC 2006 Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:1300-1306
9. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
10. 2003 Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA 290:2159-2167
11. Borch-Johnsen K, Andersen PK, Deckert T 1985 The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596
12. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH 2003 Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258-1264
13. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J 2004 Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes - the Linkoping Diabetes Complications Study. Diabetologia 47:1266-1272
14. Krolewski M, Eggers PW, Warram JH 1996 Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 50:2041-2046
15. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR 1985 The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794
16. Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C 2005 Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294:1782-1787
17. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ 2006 The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55:1463-1469
18. 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 355:253-259
19. Maahs D, Snell-Bergeon J, Kinney G, Wadwa RP, Garg S, Ogden LG, Rewers M, ACE-I/ARB Treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression coronary artery calcification. J Diabetes Complications, in press
20. Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M 2005 Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 28:1051-1056
21. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller JH; EURODIAB Prospective Complications Study Group 2004 Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27:530-537
22. Leiter LA 2005 The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract 68(Suppl 2):S3-S14
23. 2006 Standards of medical care in diabetes-2006. Diabetes Care 29(Suppl 1):S4-S42
24. Borch-Johnsen K, Kreiner S 1987 Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 294:1651-1654
25. Watts GF, Powrie JK, O'Brien SF, Shaw KM 1996 Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus. Metabolism 45:1101-1107
26. Lloyd CE, Kuller LH, Ellis D, Becker DJ, Wing RR, Orchard TJ 1996 Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 16:720-726
27. de Zeeuw D 2006 Albuminuria: a sign of vascular problems? J Am Soc Nephrol 17:2099
28. Laffel LM, McGill JB, Gans DJ 1995 The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. Am J Med 99:497-504
29. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ 2005 Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28:301-306
30. Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F, Daneman D, Dorchy H, Garandeau P, Greene SA, Hoey H, Holl RW, Kaprio EA, Kocova M, Martul P, Matsuura N, Robertson KJ, Schoenle EJ, Sovik O, Swift PG, Tsou RM, Vanelli M, Aman J; For the Hvidore Study Group on Childhood Diabetes 2001 Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 24:1342-1347
31. Perkins BA, Krolewski AS 2005 Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 5:455-463